Medicare Enrolled

Dr. Hla Myint Maung Hwang, M.D.

Nephrology · Ontario, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
1131 W 6TH ST STE 150, Ontario, CA 91762
9094824462
In practice since 2006 (19 years)
NPI: 1356357560 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hwang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hwang? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Hwang

Dr. Hla Myint Maung Hwang is a nephrology specialist in Ontario, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hwang performed 1,839 Medicare services across 668 unique beneficiaries.

Between the years covered by Open Payments, Dr. Hwang received a total of $1,345 from 16 pharmaceutical and/or device companies across 65 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Hwang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 33% volume in CA $1,345 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,839
Medicare services
Top 33% in CA for nephrology
668
Unique beneficiaries
$158
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~97 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
697 $99 $254
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
385 $176 $467
Dialysis services for patients 20 or older
Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month.
263 $290 $759
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
188 $144 $379
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
163 $141 $395
Dialysis services for adults, 2-3 visits per month
This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month.
69 $240 $633
New patient office visit, complex (60-74 min) 41 $178 $481
Monthly dialysis physician visit
A monthly doctor's visit for patients aged 20 or older who are receiving dialysis treatment.
20 $166 $438
Hemodialysis, single evaluation
A dialysis procedure to filter waste from the blood, performed with a physician's evaluation.
13 $60 $152
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,345
Total received (2018-2024)
Avg $224/year across 6 years
Top 45% in CA for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
16
Companies
65
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,302 (96.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$43 (3.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$444
2023
$371
2022
$165
2021
$40
2019
$37
2018
$289

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Ardelyx, Inc.
$150
AstraZeneca Pharmaceuticals LP
$81
Aurinia Pharma U.S., Inc.
$69
AKEBIA THERAPEUTICS INC
$43
Lilly USA, LLC
$38
CALLIDITAS THERAPEUTICS US INC.
$34
Otsuka America Pharmaceutical, Inc.
$29
Top 3 companies account for 67.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$314
Otsuka America Pharmaceutical, Inc.
$224
Ardelyx, Inc.
$167
Aurinia Pharma U.S., Inc.
$149
AKEBIA THERAPEUTICS INC
$124
GlaxoSmithKline, LLC.
$66
Lilly USA, LLC
$53
PORTOLA PHARMACEUTICALS, INC.
$44
CALLIDITAS THERAPEUTICS US INC.
$34
PFIZER INC.
$33
E.R. Squibb & Sons, L.L.C.
$33
Amgen Inc.
$22
Keryx Biopharmaceuticals, Inc.
$22
Vifor Pharma, Inc.
$22
Bayer HealthCare Pharmaceuticals Inc.
$21
La Jolla Pharmaceutical Company
$16
Top 3 companies account for 52.5% of all-time payments
Associated products mentioned in payments ›
Auryxia · BENLYSTA · BEVYXXA · ELIQUIS · FARXIGA · GIAPREZA · IBSRELA · JARDIANCE · JYNARQUE · Kerendia · LOKELMA · LUPKYNIS · Parsabiv · SAMSCA · TARPEYO · Vafseo · Veltassa
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a nephrology specialist in Ontario?
Compare nephrologists in the Ontario area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists within 10 mi
122
Per 100K population
5.6
County median income
$82,184
Nearest hospital
MONTCLAIR HOSPITAL MEDICAL CENTER
1.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Hwang is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Hwang experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Hwang performed 697 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hwang receive payments from pharmaceutical companies?
Yes. Dr. Hwang received a total of $1,345 from 16 companies across 65 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hwang's costs compare to other nephrologists in Ontario?
Dr. Hwang's average Medicare payment per service is $158. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hwang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →